News
Media
Puzzler
Publications
CME/CE
Resources
Conferences
Partnerships
Subscribe
Editorial

|Articles|January 1, 2004

Pediatric dermatology: What's your Dx?

Yellow bumps on the lips: What do they say to you? (Fordyce granules or spots)

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Related Content

Jamie Fleming, MD, discusses the underrecognition of pediatric chronic pain, urges earlier referral

Jamie Fleming, MD, discusses the underrecognition of pediatric chronic pain, urges earlier referral

ByJamie M. Fleming, MD

August 5th 2026

FDA news in pediatrics: July 2026

FDA news in pediatrics: July 2026

ByMorgan Ebert, Executive Editor

August 5th 2026

Full case: A 19-year-old boy with Down syndrome and progressive loss of communication?

Full case: A 19-year-old boy with Down syndrome and progressive loss of communication?

ByClaudia Silver, BS,Patricia Blanco, MD

August 5th 2026

When to Refer Pediatric AD and Consider JAK Inhibitors

ByLisa Swanson, MD, Ada West Dermatology

August 5th 2026

Reassessing Topical Steroid Therapy and Long-Term Safety in AD

ByLisa Swanson, MD, Ada West Dermatology

August 5th 2026

Latest CME

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

Trending on Contemporary Pediatrics

Full case: A 19-year-old boy with Down syndrome and progressive loss of communication?

FDA news in pediatrics: July 2026

When to Refer Pediatric AD and Consider JAK Inhibitors

Jamie Fleming, MD, discusses the underrecognition of pediatric chronic pain, urges earlier referral

Hot dogs, grapes, and holiday plates: Helping kids eat safely this summer